Tissue-specific effects of aldose reductase inhibition on fluorescence and cross-linking of extracellular matrix in chronic galactosemia. Relationship to pentosidine cross-links.
Chronic experimental hyperglycemia mediated by galactose has been shown to induce browning and cross-linking of rat tail tendon collagen that could be duplicated in vitro by nonenzymatic galactosylation. To investigate the nature of these changes, Sprague-Dawley rats were placed on a 33% galactose diet without and with sorbinil for 6 and 12 mo. Collagen-linked fluorescence and pentosidine cross-links increased with age and galactosemia in tail tendons (P less than 0.001) and skin but were essentially unresponsive to aldose reductase inhibition (ARI). In contrast, tendon breaking time in urea, a likely parameter of cross-linking, was markedly improved (P less than 0.001) by ARI. Fluorescence that was inhibited by sorbinil treatment was increased in pepsin and proteinase K digest of aortic tissue from galactosemic rats (P less than 0.001), but impaired enzymatic digestibility was not observed. Systolic blood pressure as potential consequence of aortic stiffening was not increased in galactosemia. These data suggest that fluorescence in skin and tendon might be in part due to advanced glycosylation and pentosidine formation because these were not decreased by ARI. However, they also suggest that nonfluorescent cross-links may also be forming because, in contrast to fluorescence, tail tendon breaking time was partly corrected by ARI. Thus, it appears that extracellular matrix changes in chronic galactosemia are complex, being partly attributable to advanced glycosylation and partly to polyol-pathway activation.
Richard
S
S
Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106.
Tamas
C
C
Sell
D R
DR
Monnier
V M
VM
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D003094:Collagen / Q000737:chemistry*; D005109:Extracellular Matrix / Q000502:physiology / Q000648:ultrastructure; D005693:Galactosemias / Q000473:pathology / Q000503:physiopathology*; D006442:Glycated Hemoglobin / Q000032:analysis; D007093:Imidazoles / Q000494:pharmacology*; D048289:Imidazolidines; D008239:Lysine / Q000031:analogs & derivatives* / Q000032:analysis; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values; D013050:Spectrometry, Fluorescence / Q000379:methods; D013710:Tendons / Q000187:drug effects / Q000473:pathology*
D000449:Aldehyde Reductase; D001120:Arginine; D003094:Collagen; D006442:Glycated Hemoglobin; D007093:Imidazoles; D048289:Imidazolidines; D008239:Lysine; C062187:pentosidine; C026411:sorbinil